Divis Laboratories gains after USFDA removes import alert imposed on Visakhapatnam unit

15 Nov 2017 Evaluate

Divis Laboratories is currently trading at Rs. 1030.15, up by 5.80 points or 0.57% from its previous closing of Rs. 1024.35 on the BSE.

The scrip opened at Rs. 1056.50 and has touched a high and low of Rs. 1060.00 and Rs. 1023.15 respectively. So far 87,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1201.05 on 15-Nov-2016 and a 52 week low of Rs. 533.10 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 1089.90 and Rs. 985.00 respectively. The current market cap of the company is Rs. 27,347.00 crore.

The promoters holding in the company stood at 52.07%, while Institutions and Non-Institutions held 32.45% and 15.48% respectively.

The US Food and Drug Administration (USFDA) h as removed the Import Alert 66-40 on Divis Laboratories’ Unit-II at Visakhapatnam. The regulator had earlier imposed the Import Alert on the company’s Unit-II at Visakhapatnam.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.


Divis Lab Share Price

4025.35 184.60 (4.81%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.